Your browser doesn't support javascript.
loading
The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.
Sica, Michela; Barone, Federica; Nannelli, Caterina; Ricci, Patrizia; Marano, Luana; De Angioletti, Maria; Di Bona, Eros; Risitano, Antonio M; Notaro, Rosario.
Affiliation
  • Sica M; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.
  • Barone F; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.
  • Nannelli C; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.
  • Ricci P; Federico II University of Naples, Naples, Italy.
  • Marano L; AORN Moscati, Avellino, Italy.
  • De Angioletti M; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.
  • Di Bona E; ICCOM-National Council of Research, Florence, Italy.
  • Risitano AM; Onco-Haematology, AULSS 7 Pedemontana, Bassano del Grappa, Italy.
  • Notaro R; Federico II University of Naples, Naples, Italy.
Br J Haematol ; 201(1): e1-e4, 2023 04.
Article in En | MEDLINE | ID: mdl-36660816
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythrocytes / Hemoglobinuria, Paroxysmal Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythrocytes / Hemoglobinuria, Paroxysmal Limits: Humans Language: En Journal: Br J Haematol Year: 2023 Type: Article Affiliation country: Italy